PortfoliosLab logoPortfoliosLab logo
ISIN
US4448591028
CUSIP
444859102
IPO Date
Jan 22, 1993

Highlights

Market Cap
$38.71B
Enterprise Value
$49.48B
EPS (TTM)
$9.37
PE Ratio
34.25
Total Revenue (TTM)
$137.20B
Gross Profit (TTM)
$13.28B
EBITDA (TTM)
$2.82B
Year Range
$163.11 - $333.31
Target Price
$225.93
ROA (TTM)
2.04%
ROE (TTM)
6.08%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

HUM Performance Chart

Humana Inc. (HUM) is up 25.9% since the beginning of the year. At $321 per share, HUM is trading 3.7% below its 52-week high of $333. Investors who bought $1,000 worth of HUM shares 5 years ago would now be looking at an investment worth $783.


Loading charts...

S&P 500 Index

Returns By Period

Humana Inc. (HUM) has returned 25.92% so far this year and 40.86% over the past 12 months. Over the last ten years, HUM has returned 6.48% per year, falling short of the S&P 500 Index benchmark, which averaged 13.75% annually.


Humana Inc.

1D
-2.26%
1M
37.35%
YTD
25.92%
6M
33.75%
1Y
40.86%
3Y*
-13.88%
5Y*
-4.78%
10Y*
6.48%

Benchmark (S&P 500 Index)

1D
0.13%
1M
5.25%
YTD
11.16%
6M
11.43%
1Y
28.20%
3Y*
21.12%
5Y*
12.66%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HUM Monthly Returns History

Based on dividend-adjusted daily data since Jan 22, 1993, HUM's average daily return is +0.07%, while the average monthly return is +1.43%. At this rate, an investment would double in approximately 4.1 years.

Historically, 57% of months were positive and 43% were negative. The best month was Jul 2000 with a return of +50.0%, while the worst month was Mar 1993 at -59.4%. The longest winning streak lasted 11 consecutive months, and the longest losing streak was 7 months.

On a daily basis, HUM closed higher 50% of trading days. The best single day was May 29, 2015 with a return of +20.3%, while the worst single day was Mar 8, 1993 at -65.6%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-23.79%-2.39%-8.54%36.36%29.17%5.06%25.92%
202515.58%-7.78%-1.83%-0.89%-11.10%5.26%2.20%21.53%-14.02%6.93%-11.65%4.57%2.36%
2024-17.42%-7.34%-0.78%-12.87%18.55%4.59%-3.22%-1.97%-10.40%-18.60%14.95%-14.10%-43.96%
2023-0.10%-3.26%-1.75%9.28%-5.40%-10.73%2.17%1.05%5.58%7.64%-7.41%-5.39%-9.94%
2022-15.38%10.65%0.38%2.16%2.18%3.22%2.98%-0.05%0.87%15.02%-1.47%-6.72%11.15%
2021-6.62%-0.90%10.61%6.20%-1.69%1.31%-3.81%-4.80%-3.84%19.02%-9.38%10.68%13.80%

Benchmark Metrics

Humana Inc. has an annualized alpha of 11.28%, beta of 0.76, and R2 of 0.11 versus S&P 500 Index. Calculated based on daily prices since January 25, 1993.

  • This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (76.18%) than losses (72.42%) - typical of diversified or defensive assets.
  • R2 of 0.11 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
11.28%
Beta
0.76
0.11
Upside Capture
76.18%
Downside Capture
72.42%

Return for Risk

Risk / Return Rank

HUM ranks 62 for risk / return — better than 62% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.


HUM Risk / Return Rank: 6262
Overall Rank
HUM Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
HUM Sortino Ratio Rank: 6161
Sortino Ratio Rank
HUM Omega Ratio Rank: 6565
Omega Ratio Rank
HUM Calmar Ratio Rank: 5959
Calmar Ratio Rank
HUM Martin Ratio Rank: 5858
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Humana Inc. (HUM) and compare them to S&P 500 Index.


HUMBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

0.84

2.39

-1.55

Sortino ratio

Return per unit of downside risk

1.34

3.25

-1.91

Omega ratio

Gain probability vs. loss probability

1.20

1.43

-0.23

Calmar ratio

Return relative to maximum drawdown

0.87

3.11

-2.24

Martin ratio

Return relative to average drawdown

1.80

14.38

-12.58

Dividends

Dividend History

Humana Inc. provided a 1.10% dividend yield over the last twelve months, with an annual payout of $3.54 per share. The company has been increasing its dividends for 9 consecutive years.


0.40%0.60%0.80%1.00%1.20%1.40%$0.00$1.00$2.00$3.00$4.0020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$3.54$3.54$3.54$3.54$3.15$2.80$2.50$2.20$2.00$1.89$0.87$1.15

Dividend yield

1.10%1.38%1.40%0.77%0.62%0.60%0.61%0.60%0.70%0.76%0.43%0.64%

Monthly Dividends

The table displays the monthly dividend distributions for Humana Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.89$0.00$0.00$0.00$0.89
2025$0.00$0.00$0.89$0.00$0.00$0.89$0.00$0.00$0.89$0.00$0.00$0.89$3.54
2024$0.00$0.00$0.89$0.00$0.00$0.89$0.00$0.00$0.89$0.00$0.00$0.89$3.54
2023$0.00$0.00$0.89$0.00$0.00$0.89$0.00$0.00$0.89$0.00$0.00$0.89$3.54
2022$0.00$0.00$0.79$0.00$0.00$0.79$0.00$0.00$0.79$0.00$0.00$0.79$3.15
2021$0.00$0.00$0.70$0.00$0.00$0.70$0.00$0.00$0.70$0.00$0.00$0.70$2.80

Dividend Yield & Payout


Dividend Yield

Humana Inc. has a dividend yield of 1.10%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.

Payout Ratio

Humana Inc. has a payout ratio of 37.96%, which is quite average when compared to the overall market. This suggests that Humana Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Humana Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Humana Inc. was 85.10%, occurring on Jun 16, 2000. Recovery took 1149 trading sessions.

The current Humana Inc. drawdown is 40.72%.


Related event

Drawdown

Fall

Recovery

Underwater

Dot-com crash2000–2002
-85.10%Jun 2000
1y 11mo4y 7mo
6y 6moJul 1998 - Jan 2005
Financial crisis2007–2009
-78.42%Mar 2009
1y 1mo2y 8mo
3y 9moJan 2008 - Nov 2011
2026 bear market2026
-69.92%Mar 2026
3y 4mo
3y 7moNov 2022 - now
1993 bear market1993
-68.82%Apr 1993
2mo 2d9mo 24d
11mo 26dFeb 1993 - Feb 1994
1996 bear market1996
-45.67%Jul 1996
5mo 2d1y 10mo
2y 3moFeb 1996 - May 1998

Drawdown Indicators


HUMBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-85.10%

-56.78%

-28.32%

Max Drawdown (1Y)

Largest decline over 1 year

-47.18%

-9.10%

-38.08%

Max Drawdown (3Y)

Largest decline over 3 years

-67.92%

-18.90%

-49.02%

Max Drawdown (5Y)

Largest decline over 5 years

-69.92%

-25.43%

-44.49%

Max Drawdown (10Y)

Largest decline over 10 years

-69.92%

-33.92%

-36.00%

Current Drawdown

Current decline from peak

-40.72%

0.00%

-40.72%

Average Drawdown

Average peak-to-trough decline

-27.15%

-10.72%

-16.43%

Ulcer Index

Depth and duration of drawdowns from previous peaks

22.79%

1.97%

+20.82%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Humana Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Humana Inc. is priced in the market compared to other companies in the Healthcare Plans industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for HUM, comparing it with other companies in the Healthcare Plans industry. Currently, HUM has a P/E ratio of 34.3. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for HUM relative to other companies in the Healthcare Plans industry. Currently, HUM has a P/S ratio of 0.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for HUM in comparison with other companies in the Healthcare Plans industry. Currently, HUM has a P/B value of 2.1. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with HUM

Add Humana Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with HUM